• HITGEN AND MSD ENTER Research Collaboration en-cphi
    March 22, 2017
    Chengdu, China,22nd March, 2017, HitGen Ltd announced that the company has entered into a collaboration with MSD, known as Merck in the United States and Canada, to discover novel chemical leads for multiple therapeutic targets of interest to MSD.
PharmaSources Customer Service